Search

everythinglearnresearchcommunity

for

Search:↓

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

A woman in Sri Lanka was diagnosed with lupus after presenting with protein loss from the gut and other symptoms.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Early treatment of pediatric lupus-related eye issues is crucial to prevent vision loss.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Surgical therapies for vitiligo vary in effectiveness, with combination therapy and medical tattooing recommended for better results.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Early diagnosis and treatment of Kaposi varicelliform eruption are crucial to prevent severe complications.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Araliadiol may promote hair growth like minoxidil without being toxic.

Lupus nephritis patients face more challenges in family planning, work, symptoms, medication, and quality of life than those without it.

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.